RxDoctor Payments Data

David Alcantara, MD

Physical Medicine & Rehabilitation · Portsmouth, VANPI 1508022351

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations.

$1,268in general payments, 2019–2025

Across 36 payments — averaging $35.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$138
  • Scpharmaceuticals Inc.$129
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$122
  • Boehringer Ingelheim$121
  • Novo Nordisk$121
  • Sanofi-aventis U.S. LLC$107
  • plus $529 from 12 others

What the payments were for

  • Food & beverage$1,268100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)2$138
Scpharmaceuticals Inc.1$129
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$122
Boehringer Ingelheim1$121
Novo Nordisk1$121
Sanofi-aventis U.S. LLC1$107
E.r. Squibb & Sons, L.L.C.1$105
Amgen7$101
Pfizer7$92
Abbott3$69
Stryker2$35
Supernus Pharmaceuticals, Inc.1$31
Kaleo, Inc.2$29
Zyla Life Sciences, Inc.2$22
Boston Scientific1$14
Lilly USA, LLC1$11
Metacel Pharmaceuticals LLC1$11
Electronic Waveform Lab, Inc.1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,268 in reported general payments places this provider in the 80th percentile of 231 physical medicine & rehabilitation providers in Virginia.

See all physical medicine & rehabilitation providers in Virginia

Medicare billing

Part B allowed, 2024
$73,290
Medicare patients
253
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin140$5,447
Gabapentin98$1,770
Diclofenac Sodium37$550
Duloxetine Hcl46$548
Cyclobenzaprine Hcl31$447
Prednisone28$344
Amitriptyline Hcl26$316
Methocarbamol12$257
Meloxicam50$174
Celecoxib12$172
Topiramate17$141
Nortriptyline Hcl16$99
Tramadol Hcl12$63

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Portsmouth

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →